Reference health
Long-Term Outcomes of COVID-19 Survivors and an Exploratory Analysis of Factors Associated with Sequela-Free Survival of Patients Treated at Leishenshan Hospital in Wuhan, China
1 of 22 checkable references need attention · checked 2026-07-22
At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.
58 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
References needing attention
marked retracted — notice via Crossref, record curated by Retraction Watch10.1016/S0140-6736(20)32656-8
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
The 21 checked references that resolve
resolves10.1016/S0140-6736(20)31605-6
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
resolves10.1177/0891988708328214
The Use of the Modified Telephone Interview for Cognitive Status (TICS-M) in the Detection of Amnestic Mild Cognitive Impairment
resolves10.1016/j.anorl.2017.06.010
The Carcinologic Handicap Index (CHI): A disability self-assessment questionnaire for head and neck cancer patients
resolves10.1016/j.cardfail.2009.08.010
Patients' Self-Assessed Functional Status in Heart Failure by New York Heart Association Class: A Prognostic Predictor of Hospitalizations, Quality of Life and Death
resolves10.1016/j.cmi.2020.09.023
Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study
resolves10.1093/eurheartj/ehaa664
Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study
resolves10.1016/j.drudis.2020.06.021
Direct SARS-CoV-2 infection of the heart potentiates the cardiovascular sequelae of COVID-19
resolves10.1002/jts.20004
Posttraumatic stress, anxiety, and depression in survivors of severe acute respiratory syndrome (SARS)
resolves10.1183/13993003.00562-2020
Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China
resolves10.2147/JIR.S280331
<p>Immunological Evaluation on Potential Treatment Window for Hospitalized COVID-19 Patients</p>
resolves10.1016/j.jamda.2020.09.003
Pandemic Care Through Collaboration: Lessons From a COVID-19 Field Hospital
resolves10.1016/S0140-6736(20)30183-5
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
resolves10.1016/j.ijid.2020.08.062
Multisystem inflammatory syndrome in children (MIS-C): Report of the clinical and epidemiological characteristics of cases in Santiago de Chile during the SARS-CoV-2 pandemic
resolves10.21037/atm-20-3391
Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters
resolves10.1007/s11739-020-02384-2
Plasma from donors recovered from the new Coronavirus 2019 as therapy for critical patients with COVID-19 (COVID-19 plasma study): a multicentre study protocol
resolves10.1186/s13063-020-04735-y
A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial
The 58 references without a DOI — listed, not checked
no DOI — not checkedCovid-19: Vaccine candidate may be more than 90% effective, interim results indicate
no DOI — not checkedSafety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
no DOI — not checkedReliability of the activities of daily living scale and its use in telephone interview
no DOI — not checkedAnalysis of thin-section CT in patients with coronavirus disease (COVID-19) after hospital discharge
no DOI — not checkedThe military intensive care field hospital, a unique experience in the fight against covid-19
no DOI — not checkedCoronavirus disease 2019 (COVID-19) related cytopenia: A protocol for systematic review and meta-analysis
no DOI — not checkedClinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19
no DOI — not checkedManagement of Hemoglobin Disorders During the COVID-19 Pandemic
no DOI — not checkedref31
no DOI — not checkedref32
no DOI — not checkedref33
no DOI — not checkedref34
no DOI — not checkedref35
no DOI — not checkedref36
no DOI — not checkedref37
no DOI — not checkedref38
no DOI — not checkedref39
no DOI — not checkedref40
no DOI — not checkedref41
no DOI — not checkedref42
no DOI — not checkedref43
no DOI — not checkedref44
no DOI — not checkedref45
no DOI — not checkedref46
no DOI — not checkedref47
no DOI — not checkedref48
no DOI — not checkedref49
no DOI — not checkedref50
no DOI — not checkedref51
no DOI — not checkedref52
no DOI — not checkedref53
no DOI — not checked2%) 46 (1�7%) Nonischemic heart diseases 0
no DOI — not checked8%) 20 (3�9%) Cerebrovascular diseases 0
no DOI — not checked4%) 15 (2�9%) Liver dysfunction 0
no DOI — not checkedref57
no DOI — not checkedref58
no DOI — not checkedref59
no DOI — not checkedref60
no DOI — not checkedTable S2: Long-term outcomes Activities of daily living Barthel Index before COVID-19 (n=459) 100 (fully independent) 422 (91�9%) 61-99 (mild residual disabled) 30 (6�5%) 41-60 (moderate residual disabled) 3 (0�7%) 21-40 (severe residual disabled) 2 (0�4%)
no DOI — not checkedref62
no DOI — not checkedref63
no DOI — not checkedref64
no DOI — not checkedref65
no DOI — not checkedref66
no DOI — not checkedref67
no DOI — not checkedref68
no DOI — not checkedref69
no DOI — not checkedref70
no DOI — not checkedref71
no DOI — not checked2%) Phonation scores before COVID-19 (n=441) Median (IQR) 0 (0, 0) Range 0-5 Phonation scores after COVID-19 (n=441) Median (IQR) 0 (0, 0) Range 0-10 Increasing of phonation scores after
no DOI — not checkedref73
no DOI — not checkedref74
no DOI — not checked1%) Vision scores before COVID-19 (n=441) Median (IQR) 0 (0, 0) Range 0-11 Vision scores after COVID-19 (n=441) Median (IQR) 0 (0, 0) Range 0-16 Increasing of vision scores after
no DOI — not checked4%) Olfaction scores before COVID-19 (n=441) Median (IQR) 0 (0, 0) Range 0-4 Olfaction scores after COVID-19 (n=441) Median (IQR) 0 (0, 0) Range 0-8 Cerebrovascular diseases
no DOI — not checkedref77
no DOI — not checkedref78
no DOI — not checkedref79
no DOI — not checkedref80
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.2139/ssrn.3920236"><img src="https://citestamp.com/citestamped/10.2139/ssrn.3920236/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.2139/ssrn.3920236)